of last year by Baht 49.5 million or is equal to 48.4% which change in the same direction of revenue. The main reason was resulting from decrease in rental expense due to discount from COVID-19

/2018-2019, in-line with reduction in food revenue. However, the Company managed raw material costs by sourcing from suppliers that offered better discount in comparison to volume and enforcing tighter

243.63 69.71 301.15 97.39 57.52 23.61 Deduct Sales discount (10.77) (3.08) (22.14) (7.16) (11.37) 105.57 Total sales 232.86 66.63 279.01 90.23 46.15 19.82 Other income/1 116.60 33.37 30.20 9.77 (86.40

Shares to Specific Investors (Private Placement) at the Offering Price with a Discount of not more than ten percent of the Market Price 2. Capital Increase Report Form (F53-4) 3. Information Memorandum on

Ticker ARKG CUSIP 00214Q 302 ISIN US00214Q3020 ดชันีชีว้ดั/อ้างอิง(Benchmark) - NASDAQ Biotech. Index - S&P 500 Index - MSCI World Index Index ticker - XNBI Index - SPX Index - M1WO Index สกลุเงิน USD ผู้

Depositary Receipt) ตลาดหลกัทรัพย์ท่ีจดทะเบยีน ตลาดหลกัทรัพย์นิวยอร์ก (NYSE Arca) ประเทศสหรัฐอเมริกา วนัจดัตัง้กองทนุ 30 กนัยายน 2557 การเปิดให้ซือ้และขายคืนหน่วยลงทนุ ทกุวนัท าการซือ้ขายหน่วยลงทนุ Fund Ticker

สารหรือสญัญา แลว้แต่กรณี “derivatives” สญัญาซ้ือขายล่วงหน้า “derivatives on organized exchange” derivatives ท่ีซ้ือขายในศูนยซ้ื์อขาย derivatives “discount rate” อตัราส่วนลดของหลกัทรพัยห์รือตราสารท่ีมี

from last year by Baht 166.43 million compared with last year mainly from short term loan for working capital and for purchasing plastic resin in cash to get cash discount. Moreover, the Company paid for

Value of Transaction : Not exceeding 400.00 million Baht. Acquisition price is determined based on Discount Cash Flow valuation conducted by the independent financial advisor and based on the negotiation

shopping center.  Reflecting to new TFRS 15, the company acknowledged less revenue concerning to reclassification of discount & allowance and sales promotion items.  Total expenses increase are mainly